<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "journalpublishing3.dtd">
<article xml:lang="en" article-type="research-article" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<?release-delay 0|0?>
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">ETM</journal-id>
<journal-title-group>
<journal-title>Experimental and Therapeutic Medicine</journal-title>
</journal-title-group>
<issn pub-type="ppub">1792-0981</issn>
<issn pub-type="epub">1792-1015</issn>
<publisher>
<publisher-name>D.A. Spandidos</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">ETM-28-6-12739</article-id>
<article-id pub-id-type="doi">10.3892/etm.2024.12739</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Articles</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Implanted cartilaginous grafts following rhinoplasty: A retrospective histopathological study</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name><surname>Matsukuma</surname><given-names>Susumu</given-names></name>
<xref rid="af1-ETM-28-6-12739" ref-type="aff">1</xref>
<xref rid="af2-ETM-28-6-12739" ref-type="aff">2</xref>
<xref rid="c1-ETM-28-6-12739" ref-type="corresp"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Matsunaga</surname><given-names>Ayano</given-names></name>
<xref rid="af1-ETM-28-6-12739" ref-type="aff">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Ogata</surname><given-names>Sho</given-names></name>
<xref rid="af1-ETM-28-6-12739" ref-type="aff">1</xref>
<xref rid="af2-ETM-28-6-12739" ref-type="aff">2</xref>
</contrib>
</contrib-group>
<aff id="af1-ETM-28-6-12739"><label>1</label>Department of Pathology and Laboratory Medicine, National Defense Medical College, Tokorozawa, Saitama 359-8513, Japan</aff>
<aff id="af2-ETM-28-6-12739"><label>2</label>Department of Laboratory Medicine, National Defense Medical College Hospital, National Defense Medical College, Tokorozawa, Saitama 359-8513, Japan</aff>
<author-notes>
<corresp id="c1-ETM-28-6-12739"><italic>Correspondence to:</italic> Dr Susumu Matsukuma, Department of Pathology and Laboratory Medicine, National Defense Medical College, 3-2 Namiki, Tokorozawa, Saitama 359-8513, Japan <email>gchen@tzc.edu.cn matsukma@ndmc.ac.jp </email></corresp>
<fn><p><italic>Abbreviations:</italic> ACC, autologous costal cartilage; ANC, autologous nasal cartilage; EC, ear cartilage; EVG, elastica van Gieson; IHCC, irradiated homologous costal cartilage; IHNC, irradiated homologous nasal cartilage; ITI, implantation time interval; LFN, lipomembranous fat necrosis; MT, Masson trichrome; PAS, periodic acid-Schiff</p></fn>
</author-notes>
<pub-date pub-type="collection">
<month>12</month>
<year>2024</year></pub-date>
<pub-date pub-type="epub">
<day>03</day>
<month>10</month>
<year>2024</year></pub-date>
<volume>28</volume>
<issue>6</issue>
<elocation-id>449</elocation-id>
<history>
<date date-type="received">
<day>16</day>
<month>07</month>
<year>2024</year>
</date>
<date date-type="accepted">
<day>13</day>
<month>09</month>
<year>2024</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x00A9; 2024, Spandidos Publications</copyright-statement>
<copyright-year>2024</copyright-year>
</permissions>
<abstract>
<p>To describe histopathological features of rhinoplasty-related implanted cartilages, 83 cartilages surgically removed from 42 patients (2 men and 40 women) with a median age of 28.0 years (range, 21-47 years) following correction/revision rhinoplasty were examined. These cartilages included 16 autologous costal cartilages (ACCs), 14 irradiated homologous costal cartilages (IHCCs), 24 autologous nasal cartilages (ANCs), 2 irradiated homologous nasal cartilages (IHNCs), 14 autologous ear cartilages (ECs) and 13 combined cartilaginous grafts. The median chondrocytic viability in ACCs (35.9&#x0025;) was higher than that of IHCCs (0.0&#x0025;) and ECs (21.4&#x0025;) (both, P&#x003C;0.001), and showed no significant differences compared with the viability in ANCs (41.3&#x0025;) (P=0.455). The median organized rate of chondroid matrix in ACCs, IHCCs, ANCs and ECs was 2.5, 1.4, 0.9 and 2.0&#x0025;, respectively, and there were no significant differences among them (P=0.909). The present study revealed not only enlarged chondrocytic lacunae, chondrocytic cloning and binucleated/trinucleated chondrocytes, but also a possible transition between chondrocytes and fibroblasts in 6 ACCs, 3 ANCs and 1 EC, lipomembranous fat necrosis (LFN)-like bodies in 15 ACCs, 14 IHCCs, 3 ANCs and 5 ECs, and chondrocytic vacuolar changes in 15 ACCs, 22 ANCs, 2 IHNCs and 16 ECs. A histological transition between LFN-like bodies and chondrocytic vacuoles was focally observed in 2 ACCs and 1 ANC. The present findings suggested that the stability of implanted cartilage did not depend on chondrocytic viability only. Viable chondrocytes preserve implanted chondroid matrix, but also may, in part, induce organization through their transformation into fibroblasts. LFN-like bodies are considered to be an underrecognized form of vacuolar change-related chondrocytic necrosis.</p>
</abstract>
<kwd-group>
<kwd>cartilage</kwd>
<kwd>implantation</kwd>
<kwd>rhinoplasty</kwd>
<kwd>histopathology</kwd>
</kwd-group>
<funding-group>
<funding-statement><bold>Funding:</bold> No funding was received.</funding-statement>
</funding-group>
</article-meta>
</front>
<body>
<sec sec-type="intro">
<title>Introduction</title>
<p>Rhinoplasty is one of the most commonly performed plastic/cosmetic surgeries worldwide (<xref rid="b1-ETM-28-6-12739 b2-ETM-28-6-12739 b3-ETM-28-6-12739 b4-ETM-28-6-12739" ref-type="bibr">1-4</xref>). Rhinoplasty is a repositioning technique of the nasal skeleton and soft tissues to improve function and/or appearance (<xref rid="b1-ETM-28-6-12739 b2-ETM-28-6-12739 b3-ETM-28-6-12739 b4-ETM-28-6-12739" ref-type="bibr">1-4</xref>). Rhinoplasty includes septoplasty (<xref rid="b1-ETM-28-6-12739" ref-type="bibr">1</xref>,<xref rid="b2-ETM-28-6-12739" ref-type="bibr">2</xref>,<xref rid="b5-ETM-28-6-12739" ref-type="bibr">5</xref>), septorhinoplasty (<xref rid="b6-ETM-28-6-12739" ref-type="bibr">6</xref>), nasal reconstruction (<xref rid="b7-ETM-28-6-12739" ref-type="bibr">7</xref>,<xref rid="b8-ETM-28-6-12739" ref-type="bibr">8</xref>), nasal dorsum augmentation (<xref rid="b1-ETM-28-6-12739" ref-type="bibr">1</xref>,<xref rid="b2-ETM-28-6-12739" ref-type="bibr">2</xref>,<xref rid="b9-ETM-28-6-12739" ref-type="bibr">9</xref>,<xref rid="b10-ETM-28-6-12739" ref-type="bibr">10</xref>), turbinoplasty (<xref rid="b1-ETM-28-6-12739" ref-type="bibr">1</xref>,<xref rid="b2-ETM-28-6-12739" ref-type="bibr">2</xref>), and nasal tip plasty/modification (<xref rid="b1-ETM-28-6-12739" ref-type="bibr">1</xref>,<xref rid="b2-ETM-28-6-12739" ref-type="bibr">2</xref>,<xref rid="b4-ETM-28-6-12739" ref-type="bibr">4</xref>,<xref rid="b9-ETM-28-6-12739" ref-type="bibr">9</xref>,<xref rid="b10-ETM-28-6-12739" ref-type="bibr">10</xref>). Rhinoplasty frequently uses autologous cartilaginous grafts, homologous cartilaginous grafts and/or alloplastic/artificial grafts to correct contour deformities and restore structural support (<xref rid="b1-ETM-28-6-12739" ref-type="bibr">1</xref>,<xref rid="b3-ETM-28-6-12739" ref-type="bibr">3</xref>,<xref rid="b4-ETM-28-6-12739" ref-type="bibr">4</xref>). Autologous cartilages are harvested from the 6-8th rib, nose, and/or ear of patients themselves (<xref rid="b1-ETM-28-6-12739" ref-type="bibr">1</xref>,<xref rid="b5-ETM-28-6-12739" ref-type="bibr">5</xref>,<xref rid="b7-ETM-28-6-12739 b8-ETM-28-6-12739 b9-ETM-28-6-12739 b10-ETM-28-6-12739 b11-ETM-28-6-12739 b12-ETM-28-6-12739 b13-ETM-28-6-12739 b14-ETM-28-6-12739 b15-ETM-28-6-12739 b16-ETM-28-6-12739" ref-type="bibr">7-16</xref>) and homologous ones are usually composed of cadaveric rib (<xref rid="b5-ETM-28-6-12739" ref-type="bibr">5</xref>,<xref rid="b11-ETM-28-6-12739" ref-type="bibr">11</xref>,<xref rid="b16-ETM-28-6-12739" ref-type="bibr">16</xref>). Surgical techniques and management for rhinoplasty have progressively improved (<xref rid="b1-ETM-28-6-12739" ref-type="bibr">1</xref>,<xref rid="b2-ETM-28-6-12739" ref-type="bibr">2</xref>,<xref rid="b9-ETM-28-6-12739" ref-type="bibr">9</xref>). Nevertheless, unexpected events or complications can occur (<xref rid="b1-ETM-28-6-12739 b2-ETM-28-6-12739 b3-ETM-28-6-12739" ref-type="bibr">1-3</xref>,<xref rid="b9-ETM-28-6-12739 b10-ETM-28-6-12739 b11-ETM-28-6-12739" ref-type="bibr">9-11</xref>), and revision rhinoplasty with removal of implanted cartilage may be required (<xref rid="b9-ETM-28-6-12739" ref-type="bibr">9</xref>,<xref rid="b14-ETM-28-6-12739" ref-type="bibr">14</xref>,<xref rid="b16-ETM-28-6-12739" ref-type="bibr">16</xref>). Such events or complications include nasal deformity/deviation/asymmetry, infection, skin necrosis, bleeding/hematoma and vestibular stenosis (<xref rid="b1-ETM-28-6-12739" ref-type="bibr">1</xref>,<xref rid="b2-ETM-28-6-12739" ref-type="bibr">2</xref>,<xref rid="b9-ETM-28-6-12739" ref-type="bibr">9</xref>). Pathological examination of the removed cartilaginous grafts can provide useful information to surgeons. Previous investigations regarding cartilage implantation have focused on cartilaginous viability and stability in human (<xref rid="b13-ETM-28-6-12739 b14-ETM-28-6-12739 b15-ETM-28-6-12739" ref-type="bibr">13-15</xref>) or animal models (<xref rid="b17-ETM-28-6-12739 b18-ETM-28-6-12739 b19-ETM-28-6-12739 b20-ETM-28-6-12739" ref-type="bibr">17-20</xref>) although they also have described calcification/ossification (<xref rid="b13-ETM-28-6-12739" ref-type="bibr">13</xref>,<xref rid="b18-ETM-28-6-12739" ref-type="bibr">18</xref>,<xref rid="b19-ETM-28-6-12739" ref-type="bibr">19</xref>), vascularization or granulation-fibrosis (<xref rid="b13-ETM-28-6-12739 b14-ETM-28-6-12739 b15-ETM-28-6-12739" ref-type="bibr">13-15</xref>,<xref rid="b17-ETM-28-6-12739 b18-ETM-28-6-12739 b19-ETM-28-6-12739" ref-type="bibr">17-19</xref>), chondrocytic cloning (<xref rid="b14-ETM-28-6-12739" ref-type="bibr">14</xref>), and mild lymphoid infiltration (<xref rid="b15-ETM-28-6-12739" ref-type="bibr">15</xref>) in implanted cartilages. To date, the detailed histopathological features/alterations of implanted cartilages remain poorly understood although cartilaginous changes are frequently mentioned in osteoarthritic conditions, rheumatoid arthritis, and some inherited diseases (<xref rid="b21-ETM-28-6-12739 b22-ETM-28-6-12739 b23-ETM-28-6-12739" ref-type="bibr">21-23</xref>). In this study, we examined surgically removed cartilages that had been implanted during a previous rhinoplasty, and attempted to define their histopathological features/changes. To the best of our knowledge, the present study is the first to describe the detailed histopathological findings of implanted human cartilages in a relatively larger series.</p>
</sec>
<sec sec-type="Materials|methods">
<title>Materials and methods</title>
<sec>
<title/>
<sec>
<title>Ethics approval</title>
<p>The present study was a retrospective study performed according to the principles of the Declaration of Helsinki, and was approved by the Ethical Review Board of the National Defense Medical College (No. 4804; April 27, 2023).</p>
</sec>
<sec>
<title>Patients, removed cartilaginous grafts, and clinicopathological investigation</title>
<p>Hematoxylin and eosin (H&#x0026;E)-stained, Masson trichrome (MT)-stained, periodic acid-Schiff (PAS)-stained, and elastica van Gieson (EVG)-stained glass slides of 83 removed cartilaginous grafts were available from Ginza Sumirenohana Clinic and were examined for pathology. All grafts were surgically removed from 42 patients (2 men and 40 women), with a median age of 28.0 years (range, 21-47 years), during correction/revision rhinoplasty at Ginza Sumirenohana Clinic, Tokyo, Japan, between January 2016 and March 2023. All specimens were fixed with 10-20&#x0025; buffered formalin, paraffin-embedded, and routinely processed. Clinical information including time interval between implantation and graft removal, termed implantation time interval (ITI), was available from the request forms for pathological examination, and additionally obtained from the attending physician at the clinic. According to previous investigations (<xref rid="b17-ETM-28-6-12739" ref-type="bibr">17</xref>,<xref rid="b20-ETM-28-6-12739" ref-type="bibr">20</xref>), we defined chondrocytic viability as nucleated cell count (&#x0025;) within chondrocytic lacunae. The organized rate of chondroid matrix was calculated as the replacement-fibrotic areas (&#x0025;) within possible initial chondroid areas. Pathological changes were graded as follows: 0, none; 1, mild; 2, mild to moderate; 3, moderate; 4, moderate to marked; and 5, marked. Histological assessment was performed using an Olympus BX51 microscope (Olympus, Tokyo, Japan).</p>
</sec>
<sec>
<title>Statistical analysis</title>
<p>We analyzed the clinicopathological differences between cartilaginous types using the chi-square test, Fisher&#x0027;s exact test, Mann-Whitney <italic>U</italic>-test with or without Bonferroni correction, and Kruskal-Wallis <italic>H</italic>-test. Statistical significance was set at P&#x003C;0.05. To compare data among &#x2265;3 cartilage types, Kruskal-Wallis <italic>H</italic>-test analysis was applied first. If there was a significant difference of variables between them, we further analyzed difference between two cartilage types using Mann-Whitney <italic>U</italic>-test with Bonferroni correction.</p>
</sec>
</sec>
</sec>
<sec sec-type="Results">
<title>Results</title>
<sec>
<title/>
<sec>
<title>Clinical findings and histological type of removed cartilaginous grafts</title>
<p><xref rid="tI-ETM-28-6-12739" ref-type="table">Table I</xref> shows a summary of clinical findings. ITI ranged from 0.3 to 132 months (median, 18.0 months). Main complaints/reasons for surgery included nasal deformity (24 patients), nasal discomfort (15 patients), and skin thinning at the implantation site (10 patients). Based on histological characteristics (<xref rid="b7-ETM-28-6-12739" ref-type="bibr">7</xref>,<xref rid="b24-ETM-28-6-12739 b25-ETM-28-6-12739 b26-ETM-28-6-12739" ref-type="bibr">24-26</xref>), removed cartilages were divided into articular/costal hyaline cartilages, nasal (hyaline) cartilages (NCs), and elastic cartilages. Additional clinical information concluded that articular/costal hyaline cartilages corresponded to costal cartilages (CCs) composed of autologous CCs (ACCs) and irradiated homologous CCs (IHCCs). NCs were subdivided into autologous NCs (ANCs) and irradiated homologous NCs (IHNCs), and all ECs corresponded to autologous ear cartilages (ECs). CCs were usually triangular or diced, and contained evenly distributed chondrocytes/lacunae (<xref rid="f1-ETM-28-6-12739" ref-type="fig">Fig. 1A</xref> and <xref rid="f1-ETM-28-6-12739" ref-type="fig">B</xref>). NCs and ECs were frequently elongated and slightly curved (<xref rid="f1-ETM-28-6-12739" ref-type="fig">Fig. 1F</xref> and <xref rid="f1-ETM-28-6-12739" ref-type="fig">K</xref>), and were sometimes fragmented. Chondrocytes/chondrocytic lacunae in NCs and ECs were sparse centrally and relatively dense peripherally (<xref rid="f1-ETM-28-6-12739" ref-type="fig">Fig. 1G</xref> and <xref rid="f1-ETM-28-6-12739" ref-type="fig">L</xref>). Scattered empty chondrocyte lacunae indicated chondrocyte necrosis. On H&#x0026;E-stained sections, chondroid matrix in CCs and NCs was slightly eosinophilic and homogeneous, whereas that in ECs was brightly red (<xref rid="f1-ETM-28-6-12739" ref-type="fig">Fig. 1C</xref>, <xref rid="f1-ETM-28-6-12739" ref-type="fig">H</xref> and <xref rid="f1-ETM-28-6-12739" ref-type="fig">M</xref>). MT stain highlighted unstained chondrocytic lacunae, with NC chondrocyte lacunae somewhat larger than those of CCs and ECs (<xref rid="f1-ETM-28-6-12739" ref-type="fig">Fig. 1D</xref>, <xref rid="f1-ETM-28-6-12739" ref-type="fig">I</xref> and <xref rid="f1-ETM-28-6-12739" ref-type="fig">N</xref>). ECs were characterized by a dense elastic meshwork (<xref rid="f1-ETM-28-6-12739" ref-type="fig">Fig. 1O</xref>). CCs and NCs lacked this dense elastic meshwork, but had occasional EVG-positive fine deposits (<xref rid="f1-ETM-28-6-12739" ref-type="fig">Fig. 1E</xref> and <xref rid="f1-ETM-28-6-12739" ref-type="fig">J</xref>). Thirteen grafts were composed of &#x2265;2 different types of cartilages and/or artificial grafts (combined grafts). Consequently, a total of 83 grafts were divided into 14 ACCs only, 16 IHCCs only, 24 ANCs only, 2 IHNCs only, 14 ECs only, and 13 combined grafts (<xref rid="tII-ETM-28-6-12739" ref-type="table">Table II</xref>). We examined 16 ACCs (14 ACCs only and 2 ACCs in combined grafts), 18 IHCCs (16 IHCCs only and 2 IHCCs in combined grafts), 33 ANCs (24 ANCs only and 9 ANCs in combined grafts), 2 IHNCs only, and 23 ECs (14 ECs only and 9 ECs in combined grafts).</p>
</sec>
<sec>
<title>Histopathological features of removed cartilaginous grafts</title>
<p><xref rid="tIII-ETM-28-6-12739" ref-type="table">Table III</xref> summarizes clinicopathological features of the cartilaginous grafts. Granulation-fibrosis surrounded 11 ACCs, 9 IHCCs, 24 ANCs, and 22 ECs. Mild lymphoid infiltration was found in 5 ACCs, 6 IHCCs, 11 ANCs, and 7 ECs. Neutrophilia, suggesting bacterial infection, was not found in any removed cartilages.</p>
</sec>
<sec>
<title>CCs</title>
<p>All 16 ACCs contained viable chondrocytes. IHCCs were mostly necrotic and 3 IHCCs had a few viable chondrocytes. Median chondrocytic viability was 35.9&#x0025; in ACCs and 0.0&#x0025; in IHCCs. Chondroid matrix was partially organized in all ACCs and in 16 IHCCs (<xref rid="f2-ETM-28-6-12739" ref-type="fig">Fig. 2A</xref> and <xref rid="f2-ETM-28-6-12739" ref-type="fig">B</xref>). The median organized rate was 2.5&#x0025; in ACCs and 1.4&#x0025; in IHCCs. Organizing fibroblasts were not stained with PAS, whereas chondrocytes were PAS-positive. In 6 ACCs, PAS-positive spindle chondrocytes and PAS-negative fibroblastic spindle cells were intermingled near the organized areas, indicating a possible transition between chondrocytes and fibroblasts (<xref rid="f2-ETM-28-6-12739" ref-type="fig">Fig. 2C</xref> and <xref rid="f2-ETM-28-6-12739" ref-type="fig">D</xref>). The median grading score of enlarged chondrocytic lacunae of both ACCs and IHCCs was 3.0. Newly developed minimal elastic fibers were found (<xref rid="f2-ETM-28-6-12739" ref-type="fig">Fig. 2E</xref>) in 8 ACCs and 6 IHCCs. Eosinophilic serpiginous membranous bodies (<xref rid="f2-ETM-28-6-12739" ref-type="fig">Fig. 2F</xref>) were identified in 15 ACCs and 14 IHCCs. These bodies were red with MT and PAS stains (<xref rid="f2-ETM-28-6-12739" ref-type="fig">Fig. 2F</xref>, inset), mimicking lipomembranous fat necrosis (LFN) (<xref rid="b27-ETM-28-6-12739" ref-type="bibr">27</xref>,<xref rid="b28-ETM-28-6-12739" ref-type="bibr">28</xref>). The median grading score of these LFN-like bodies was 1.5 in ACCs and 1.0 in IHCCs. Chondrocytic cloning, binucleated chondrocytes, and chondrocytic vacuolar changes (<xref rid="f2-ETM-28-6-12739" ref-type="fig">Fig. 2G</xref>) were found in 14, 15, and 15 ACCs, respectively, and the median grading score was 2.0, 1.0, and 3.0, respectively. A histological transition between chondrocytic vacuoles and LFN-like bodies was occasionally observed in 2 ACCs (<xref rid="f2-ETM-28-6-12739" ref-type="fig">Fig. 2H</xref>). In IHCCs, chondrocytic cloning, binucleated chondrocytes, and chondrocytic vacuoles were not observed. Trinucleated chondrocytes were not found in any of the CCs.</p>
<p><italic>NCs.</italic> All 35 NCs contained viable chondrocytes. Median chondrocytic viability was 38.8&#x0025; in ANCs and 25.8&#x0025; in IHNCs, with no significant difference between them (P=0.105; Mann-Whitney <italic>U</italic>-test without Bonferroni correction). Median organized rate was 0.9&#x0025; in ANCs and 0.01&#x0025; in IHNCs. Organizing fibroblasts invaded chondroid matrix in a striated (<xref rid="f3-ETM-28-6-12739" ref-type="fig">Fig. 3A</xref>) or nested (<xref rid="f3-ETM-28-6-12739" ref-type="fig">Fig. 3B</xref>) fashion. There was a possible transition between PAS-positive chondrocytes and fibroblasts in 3 ANCs (<xref rid="f3-ETM-28-6-12739" ref-type="fig">Fig. 3C</xref> and <xref rid="f3-ETM-28-6-12739" ref-type="fig">D</xref>). In 1 ANC, there was a fibrous nodule containing many PAS-positive spindle cells (<xref rid="f3-ETM-28-6-12739" ref-type="fig">Fig. 3E</xref>), suggesting fibrocartilaginous metaplasia of ANC. The median grading score of enlarged chondrocytic lacunae was 2.0 in ANCs and 4.0 in IHNC. Elastic fibers were not observed in NCs. LFN-like bodies were found in 3 ANCs, but not in IHNCs. The median grading scores of chondrocytic cloning and binucleated chondrocytes in ANCs were 2.0 and 1.0, respectively, and those in IHNCs were 3.0 and 2.0, respectively. Trinucleated chondrocytes were observed in 8 ANCs (<xref rid="f3-ETM-28-6-12739" ref-type="fig">Fig. 3F</xref>) and in 2 IHNCs. The median grading score of chondrocytic vacuolar changes in both ANC and IHNC was 1.0. Chondrocytic vacuoles and LFN-like bodies were focally intermingled in 1ANC (<xref rid="f3-ETM-28-6-12739" ref-type="fig">Fig. 3G</xref>).</p>
<p><italic>ECs.</italic> Median chondrocytic viability and median organized rate of removed ECs were 21.4 and 2.0&#x0025;, respectively. Organized areas consisted of neovascularized fibrous tissues lacking elastic meshwork (<xref rid="f4-ETM-28-6-12739" ref-type="fig">Fig. 4A</xref> and <xref rid="f4-ETM-28-6-12739" ref-type="fig">B</xref>). Near organized areas in 15 ECs, there were patchy degenerated chondroid areas lacking collagenous matrix blue stained by MT but preserving the elastic meshwork (<xref rid="f4-ETM-28-6-12739" ref-type="fig">Fig. 4A-C</xref>; asterisks). In 1 EC, there was a possible transition between chondrocytes and fibroblasts (<xref rid="f4-ETM-28-6-12739" ref-type="fig">Fig. 4D</xref> and <xref rid="f4-ETM-28-6-12739" ref-type="fig">E</xref>). The median grading score of enlarged chondrocytic lacunae was 1.0. LFN-like bodies (<xref rid="f4-ETM-28-6-12739" ref-type="fig">Fig. 4F-H</xref>) were observed in 5 ECs, and the median grading score was 0. The median grading scores for chondrocytic cloning (<xref rid="f4-ETM-28-6-12739" ref-type="fig">Fig. 4I</xref>) and binucleated chondrocytes (<xref rid="f4-ETM-28-6-12739" ref-type="fig">Fig. 4J</xref>) were 1.0 and 3.0, respectively. Trinucleated chondrocytes (<xref rid="f4-ETM-28-6-12739" ref-type="fig">Fig. 4K</xref>) were found in 2 ECs. The mean grading score of chondrocytic vacuolar changes (<xref rid="f4-ETM-28-6-12739" ref-type="fig">Fig. 4J</xref>) was 1.0. The histological transition between vacuolar chondrocytes and LFN-like bodies was unclear in all ECs.</p>
</sec>
<sec>
<title>Statistical analysis of clinicopathological findings of implanted cartilaginous grafts</title>
<p>The incidence of ossification in ACC, IHCC, ANC, and EC was 12.5, 11.1, 15.1, and 0&#x0025;, respectively (<xref rid="tIII-ETM-28-6-12739" ref-type="table">Table III</xref>). There was no significant difference between them (P=0.549, Fisher&#x0027;s exact test). The incidence of lymphoid infiltration in ACC, IHCC, ANC, and EC was 31.3, 33.3, 33.3, and 30.4&#x0025;, respectively (<xref rid="tIII-ETM-28-6-12739" ref-type="table">Table III</xref>), and there was no significant difference between them (P=0.996, nxm chi-square test). <xref rid="f5-ETM-28-6-12739" ref-type="fig">Fig. 5</xref> shows comparisons of other clinicopathological findings among cartilaginous types. Kruskal-Wallis <italic>H</italic>-test revealed no significant difference of ITI or organized rate between ACC, IHCC, ANC, and EC (<xref rid="f5-ETM-28-6-12739" ref-type="fig">Fig. 5A</xref> and <xref rid="f5-ETM-28-6-12739" ref-type="fig">C</xref>) and no significant difference of grading score for binucleated chondrocytes between ACC, ANC, and EC (<xref rid="f5-ETM-28-6-12739" ref-type="fig">Fig. 5G</xref>). On the other hand, Kruskal-Wallis <italic>H</italic>-test demonstrated a significant difference of grading score for chondrocytic viability, enlarged chondrocytic lacunae, and LFN-like bodies among ACC, IHCC, ANC, and EC, (all, P&#x003C;0.001) and a significant difference of grading score for chondrocytic cloning and vacuolar change between ACC, ANC, and EC (both, P&#x003C;0.001). Chondrocytic viability in IHCC was lower than that in the others (all, P&#x003C;0.001), and that in ECs was lower than that in ACCs and ANCs (both, P&#x003C;0.001) (<xref rid="f5-ETM-28-6-12739" ref-type="fig">Fig. 5B</xref>). The grading score of enlarged chondrocytic lacunae was lower than that of the others (all, P&#x003C;0.001) (<xref rid="f5-ETM-28-6-12739" ref-type="fig">Fig. 5D</xref>). The grading score of LFN-like bodies in ACCs and IHCCs was higher than that in ANCs and ECs (<xref rid="f5-ETM-28-6-12739" ref-type="fig">Fig. 5E</xref>). The grading score of chondrocytic cloning features in ECs was lower than that of ACCs and ANCs (both, P&#x003C;0.001) (<xref rid="f5-ETM-28-6-12739" ref-type="fig">Fig. 5F</xref>). The grading score of chondrocytic vacuolar changes in ACCs was significantly higher than that in ANCs and ECs (both, P&#x003C;0.001) (<xref rid="f5-ETM-28-6-12739" ref-type="fig">Fig. 5H</xref>). The higher grading scores of LFN-like bodies in ACCs were closely associated with higher grading scores of chondrocytic vacuolar changes (P=0.026), but this was not found in ANCs or ECs (<xref rid="tIV-ETM-28-6-12739" ref-type="table">Table IV</xref>). A close relationship between the presence of trinucleated chondrocytes and increasing binucleated chondrocytes was found in ANCs (P=0.001), but not in ECs (<xref rid="tV-ETM-28-6-12739" ref-type="table">Table V</xref>).</p>
</sec>
</sec>
</sec>
<sec sec-type="Discussion">
<title>Discussion</title>
<p>The present histological examination could distinguish NCs and elastic cartilages from articular cartilages/CCs. However, because of close histological similarities, discrimination of CCs from articular cartilages is challenging and would require additional clinical information. NCs are known to be hyaline cartilages containing elastin elements (<xref rid="b24-ETM-28-6-12739" ref-type="bibr">24</xref>,<xref rid="b29-ETM-28-6-12739" ref-type="bibr">29</xref>). However, in the present NCs, elastic fibers were not found. On the other hand, in 14 of 34 CCs (32.4&#x0025;), possibly newly developed elastic fibers were observed although they were focal and minimal. Radiation induces chondrocytic necrosis, which would be a hallmark for irradiated history. Indeed, in this study, chondrocytic viability of IHCC was significantly lower than that of ACC. However, there was no significant difference of chondrocytic viability between IHNCs and ANCs. Sinclair and Walsh (<xref rid="b30-ETM-28-6-12739" ref-type="bibr">30</xref>) measured chondrocyte numbers per square millimeter of IHCCs ranging from 591 and 281, which is higher than chondrocytic viability in the current IHCCs. These findings would be accounted for by the difference in radiation dose. In the present study, chondrocyte viability in IHNC was high and this was attributed to low radiation dose.</p>
<p>Cartilages are nourished by diffusion or permeation from surrounding tissues or fluid, without direct vascular supply (<xref rid="b19-ETM-28-6-12739" ref-type="bibr">19</xref>,<xref rid="b25-ETM-28-6-12739" ref-type="bibr">25</xref>,<xref rid="b26-ETM-28-6-12739" ref-type="bibr">26</xref>,<xref rid="b31-ETM-28-6-12739" ref-type="bibr">31</xref>). A previous investigation (<xref rid="b19-ETM-28-6-12739" ref-type="bibr">19</xref>) suggested that smaller implanted cartilages are more viable than larger ones because smaller cartilages can receive richer diffusion nourishment. Greater chondrocyte viability avoids organization or absorption of chondroid matrix, which would play a critical role in the stability of implanted cartilages on rhinoplasty (<xref rid="b13-ETM-28-6-12739 b14-ETM-28-6-12739 b15-ETM-28-6-12739" ref-type="bibr">13-15</xref>). In the current study, however, chondrocytic viability of ECs was significantly lower than ACCs, ANCs, and ECs, but there was no significant difference of organized rate among them. Vila <italic>et al</italic> (<xref rid="b11-ETM-28-6-12739" ref-type="bibr">11</xref>) also reported no difference in absorption rate between IHCCs and ACCs. These findings suggest that the stability of implanted chondroid matrix does not depend on only chondrocyte viability. Furthermore, the current study revealed a possible transition between chondrocytes and fibroblasts. Dedifferentiation or fibroblastic transformation of chondrocytes can occur in osteoarthritic articular cartilages (<xref rid="b23-ETM-28-6-12739" ref-type="bibr">23</xref>). These findings indicate a possibility that viable chondrocytes not only preserve chondroid matrix but also transform into fibroblasts, inducing organization. In the present study, such possible transition between chondrocytes and fibroblasts was not rare (37.5&#x0025; of ACCs, 9.1&#x0025; of ANCs, and 4.3&#x0025; of ECs). The molecular mechanism regarding the transition of chondrocytes into a fibroblastic phenotype remains poorly understood, although the transition is related to decreased gene expression of SOX9 and <italic>COL2A1</italic>, suppressed production of aggrecan, and increased expression of <italic>COL1A1</italic> (<xref rid="b32-ETM-28-6-12739" ref-type="bibr">32</xref>,<xref rid="b33-ETM-28-6-12739" ref-type="bibr">33</xref>). Such transition would lead to a mechanically weak chondroid matrix (<xref rid="b33-ETM-28-6-12739" ref-type="bibr">33</xref>), possibly resulting in provoking unexpected degeneration and/or resorption of the implanted cartilaginous graft. In fact, in one ANC, a possible fibrocartilaginous metaplasia was found. However, the current study failed to reveal pathogeneses determining whether chondrocytes avoid or induce organization or fibrocartilaginous metaplasia. The association of chondrocyte dedifferentiation with the stability of implanted cartilages is unclear. To elucidate these points, further investigations are required.</p>
<p>The current study identified unique LFN-like bodies in 93.8&#x0025; of ACCs, 77.8&#x0025; of IHCCs, 9.1&#x0025; of ANCs, and 21.8&#x0025; of ECs. To our knowledge, LFN-like bodies in cartilages have not been mentioned previously in any cartilaginous conditions, including osteoarthritis, rheumatoid arthritis, or metabolic diseases (<xref rid="b21-ETM-28-6-12739 b22-ETM-28-6-12739 b23-ETM-28-6-12739" ref-type="bibr">21-23</xref>). We initially predicted LFN-like bodies as sclerotic changes of chondrocytic lacunar &#x2018;capsules&#x2019; (<xref rid="b25-ETM-28-6-12739" ref-type="bibr">25</xref>). However, in 2 ACCs and 1 ANC, an occasional histological transition between LFN-like bodies and chondrocytic vacuoles was observed. There was a statistically significant relationship between chondrocytic vacuolar changes and LFN-like bodies in ACCs. These findings suggest that LFN-like bodies are a vacuolar change-related necrotic form of chondrocytes themselves. Chondrocytic vacuolar changes can occur in the hypertrophic zone of the maturing epiphyseal growth plate (<xref rid="b23-ETM-28-6-12739" ref-type="bibr">23</xref>) and in achondrogenesis (<xref rid="b21-ETM-28-6-12739" ref-type="bibr">21</xref>,<xref rid="b23-ETM-28-6-12739" ref-type="bibr">23</xref>) and fibrochondrogenesis (<xref rid="b23-ETM-28-6-12739" ref-type="bibr">23</xref>). Chondrocytic vacuoles in achondrogenesis indicate some metabolic abnormalities in chondrocytes (<xref rid="b21-ETM-28-6-12739" ref-type="bibr">21</xref>). The presence of implanted chondrocytic vacuoles may imply similar metabolic abnormalities.</p>
<p>The current study of implanted cartilages also detected other histological features, such as enlarged chondrocytic lacunae, chondrocytic cloning, increased binucleated chondrocytes, and trinucleated chondrocytes. Enlarged chondrocytic lacunae represent degenerative changes of chondroid matrix. Chondrocytic cloning is associated with possible intrinsic cartilaginous repair or regeneration in osteoarthritic articular cartilages (<xref rid="b22-ETM-28-6-12739" ref-type="bibr">22</xref>,<xref rid="b23-ETM-28-6-12739" ref-type="bibr">23</xref>). Therefore, both chondrocyte cloning and more binucleated chondrocytes in implanted cartilages may indicate chondrocytic reactive proliferation, although binucleated chondrocytes are common in normal articular (<xref rid="b23-ETM-28-6-12739" ref-type="bibr">23</xref>) and nasal septal (<xref rid="b13-ETM-28-6-12739" ref-type="bibr">13</xref>) cartilage. Trinucleated chondrocytes would not be recognized in normal cartilages, but can occur in atelosteogenesis (<xref rid="b23-ETM-28-6-12739" ref-type="bibr">23</xref>). The presence of trinucleated chondrocytes in the present ANCs was statistically associated with more binucleated chondrocytes. However, this tendency was unclear in ECs and trinucleated chondrocytes were not found in ACCs despite frequent binucleated chondrocytes. These findings suggest differences of chondrocytic natures or responses among CC, NC, and EC. In this study, the grading score of chondrocyte cloning in ECs was significantly lower than that in ACCs and ANCs. Similarly, the grading score of enlarged chondrocyte lacunae in ECs was lower than that in ACCs, IHCCs, and ANCs. These differences would contribute to the amount of elastic fibers in the chondroid matrix. Elastic fibers in ECs are more prominent compared with those in CCs and NCs, and tightly surround the chondrocytes and their lacunae. Therefore, chondrocytes are less likely to form clones and lacunae would be less prone to enlarge. The relationship between these histopathological differences and the outcomes of implanted cartilages remains unclear in the present study. However, further studies would provide histopathological markers that predicts unexpected graft resorption and future weakening of cartilaginous quality in rhinoplasty.</p>
<p>In 15 ECs, near organized areas, there were patchy degenerated chondroid areas, where the elastic meshwork was preserved but collagenous elements were depleted. These degenerated features may be another pathogenesis that contributed to absorption of implanted elastic cartilages. Unfortunately, these chondroid degenerated lesions could not be assessed in detail in this study. Additional Safranin-O staining detecting the amount of proteoglycan (<xref rid="b13-ETM-28-6-12739" ref-type="bibr">13</xref>,<xref rid="b17-ETM-28-6-12739" ref-type="bibr">17</xref>,<xref rid="b34-ETM-28-6-12739" ref-type="bibr">34</xref>) may be useful to evaluate these lesions. Further immunohistochemical examination using antibodies against alpha-smooth muscle actin and S-100 protein may provide effective evidence of transition between fibroblasts and chondrocytes although paraffin-embedded specimens were not available in the present study.</p>
<p>Another limitation of the current study is using symptomatically removed cartilages. Asymptomatic implanted cartilages were not removed, and their histological changes were not examined. Therefore, the true incidences of the histopathological changes in cartilaginous grafts including asymptomatic ones remain unknown. Histopathological findings of original cartilaginous grafts at the time of initial rhinoplasty, such as original graft size, initial chondrocytic viability, and degrees of chondrocyte cloning, were not available and comparative analyses were not performed. In addition, the present study examined not only one cartilage type, but also combined cartilaginous grafts composed of &#x2265;2 different types of cartilages. Unknown interrelationships between these complicated cartilages may occur, and the histopathological data regarding each cartilaginous type in the present study would be heterogeneous. Furthermore, for a control study, the surgical pathology files of the Department of Laboratory Medicine, National Defense Medical College Hospital (from 2010 to 2023), were searched for cases of surgically removed CC, NC, and EC. Unfortunately, however, sufficient specimens for a control study were not available because the excision of these cartilages was rare in the usual surgical treatment setting. Nevertheless, we believe that the present study reveals the detailed histopathological findings of implanted cartilaginous grafts.</p>
<p>In conclusion, the present study classified removed cartilaginous grafts into ACCs, IHCCs, ANCs, IHACs, and ECs, and demonstrated their histopathological changes, including underrecognized LFN-like chondrocytic necrosis and a possible transformation of implanted chondrocytes into fibroblasts. We believe that further collected data of these features could provide useful information evaluating implanted cartilages not only in rhinoplasty but also in other body regions.</p>
</sec>
</body>
<back>
<ack>
<title>Acknowledgements</title>
<p>The authors would like to thank Dr Toshiya Yokoyama (Ginza Sumirenohana Clinic, Tokyo, Japan) for kindly providing the study specimens and clinical information, and Mr. Yoshimi Shimada (SKK Soshikikagaku Kenkyujo, Hodogaya, Yokohama, Kanagawa, Japan) for his assistance with pathology.</p>
</ack>
<sec sec-type="data-availability">
<title>Availability of data and materials</title>
<p>The data generated in the present study are not publicly available due to the nature of the research in which participants did not agree for their data to be shared publicly but may be requested from the corresponding author.</p>
</sec>
<sec>
<title>Authors&#x0027; contributions</title>
<p>SM conceived and designed the study. SM examined cartilaginous grafts, reviewed previous articles and drafted the manuscript. AM helped with the examination of cartilaginous grafts and reviewed most of the reference articles. SO also participated in the histopathological examination of removed cartilaginous grafts, provided comments regarding subsequent changes of implanted cartilages, and edited the manuscript. All authors discussed the assessment of histopathological findings of implanted cartilages. SM and AM confirm the authenticity of all the data. All authors have read and approved the final manuscript.</p>
</sec>
<sec>
<title>Ethics approval and consent to participate</title>
<p>The present study was conducted according to the principles of the Declaration of Helsinki, and was approved by the Ethical Review Board of the National Defense Medical College (approval no. 4804; April 27, 2023; Tokorozawa, Japan). The present study was a retrospective study. Patients were not required to give written informed consent for the present study because the analysis used anonymous clinicopathological data that were obtained after each patient agreed to treatment by written consent. The opt-out method was applied to obtain consent for participation in the present study using a poster. Oral informed consent of all patients for participation in the present study was obtained by the attending physician.</p>
</sec>
<sec>
<title>Patient consent for publication</title>
<p>The opt-out method was applied to obtain patient consent for publication of the present study using a poster. The poster was approved by the Ethical Review Board of the National Defense Medical College (approval no. 4804). Oral informed consent of all patients for publication of the present study was obtained by the attending physician.</p>
</sec>
<sec sec-type="COI-statement">
<title>Competing interests</title>
<p>The authors declare that they have no competing interests.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="b1-ETM-28-6-12739"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rohrich</surname><given-names>RJ</given-names></name><name><surname>Ahmad</surname><given-names>J</given-names></name></person-group><article-title>Rhinoplasty</article-title><source>Plast Reconstr Surg</source><volume>128</volume><fpage>49e</fpage><lpage>73e</lpage><year>2011</year><pub-id pub-id-type="pmid">21788798</pub-id><pub-id pub-id-type="doi">10.1097/PRS.0b013e31821e7191</pub-id></element-citation></ref>
<ref id="b2-ETM-28-6-12739"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fichman</surname><given-names>M</given-names></name><name><surname>Piedra Buena</surname><given-names>IT</given-names></name></person-group><comment>Rhinoplasty. In: StatPearls (Internet). StatPearls Publishing, Treasure Island, FL, 2023.</comment></element-citation></ref>
<ref id="b3-ETM-28-6-12739"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dayan</surname><given-names>E</given-names></name><name><surname>Rohrich</surname><given-names>RJ</given-names></name></person-group><article-title>Developing consistency in rhinoplasty</article-title><source>Plast Reconstr Surg Glob Open</source><volume>8</volume><issue>e2697</issue><year>2020</year><pub-id pub-id-type="pmid">32440395</pub-id><pub-id pub-id-type="doi">10.1097/GOX.0000000000002679</pub-id></element-citation></ref>
<ref id="b4-ETM-28-6-12739"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>JH</given-names></name><name><surname>Kim</surname><given-names>GW</given-names></name><name><surname>Kang</surname><given-names>WK</given-names></name></person-group><article-title>Nasal tip plasty using three-dimensional printed polycaprolactone (Smart Ball<sup>&#x00AE;</sup>)</article-title><source>Yeungnam Univ J Med</source><volume>37</volume><fpage>32</fpage><lpage>39</lpage><year>2002</year><pub-id pub-id-type="pmid">31661758</pub-id><pub-id pub-id-type="doi">10.12701/yujm.2019.00290</pub-id></element-citation></ref>
<ref id="b5-ETM-28-6-12739"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jang</surname><given-names>YJ (ed)</given-names></name></person-group><comment>Rhinoplasty and septoplasty. 1st edition. Koonja Publishing, Seoul, 2014.</comment></element-citation></ref>
<ref id="b6-ETM-28-6-12739"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miyawaki</surname><given-names>T</given-names></name><name><surname>Tsumiyama</surname><given-names>S</given-names></name><name><surname>Umeda</surname><given-names>G</given-names></name><name><surname>Moriyama</surname><given-names>W</given-names></name><name><surname>Mori</surname><given-names>E</given-names></name><name><surname>Asaka</surname><given-names>D</given-names></name><name><surname>Iimura</surname><given-names>J</given-names></name><name><surname>Otori</surname><given-names>N</given-names></name></person-group><article-title>Plastic surgery principles in septorhinoplasty. -Importance of the caudal septum in the treatment of caudal septal deviationa-</article-title><source>Nihon Bikagaku Gakkaishi</source><volume>57</volume><fpage>637</fpage><lpage>646</lpage><year>2018</year><comment>(Japanese)</comment></element-citation></ref>
<ref id="b7-ETM-28-6-12739"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Griffin</surname><given-names>MF</given-names></name><name><surname>Premakumar</surname><given-names>Y</given-names></name><name><surname>Seifalian</surname><given-names>AM</given-names></name><name><surname>Szarko</surname><given-names>M</given-names></name><name><surname>Butler</surname><given-names>PE</given-names></name></person-group><article-title>Biomechanical characterization of the human nasal cartilages; implications for tissue engineering</article-title><source>J Mater Sci Mater Med</source><volume>27</volume><issue>11</issue><year>2016</year><pub-id pub-id-type="pmid">26676857</pub-id><pub-id pub-id-type="doi">10.1007/s10856-015-5619-8</pub-id></element-citation></ref>
<ref id="b8-ETM-28-6-12739"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shah</surname><given-names>R</given-names></name><name><surname>Alford</surname><given-names>EL</given-names></name></person-group><article-title>Reconstructive rhinoplasty using cadaver cartilage in relapsing polychondritis</article-title><source>Proc (Bayl Univ Med Cent)</source><volume>36</volume><fpage>130</fpage><lpage>131</lpage><year>2022</year><pub-id pub-id-type="pmid">36578604</pub-id><pub-id pub-id-type="doi">10.1080/08998280.2022.2114067</pub-id></element-citation></ref>
<ref id="b9-ETM-28-6-12739"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jin</surname><given-names>HR</given-names></name><name><surname>Won</surname><given-names>TB</given-names></name></person-group><article-title>Recent advances in Asian rhinoplasty</article-title><source>Auris Nasus Larynx</source><volume>38</volume><fpage>157</fpage><lpage>164</lpage><year>2011</year><pub-id pub-id-type="pmid">20728295</pub-id><pub-id pub-id-type="doi">10.1016/j.anl.2010.05.014</pub-id></element-citation></ref>
<ref id="b10-ETM-28-6-12739"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wright</surname><given-names>JM</given-names></name><name><surname>Halsey</surname><given-names>JN</given-names></name><name><surname>Rottgers</surname><given-names>SA</given-names></name></person-group><article-title>Dorsal augmentation: A review of current graft options</article-title><source>Eplasty</source><volume>23</volume><issue>e4</issue><year>2023</year><pub-id pub-id-type="pmid">36817363</pub-id></element-citation></ref>
<ref id="b11-ETM-28-6-12739"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vila</surname><given-names>PM</given-names></name><name><surname>Jeanpierre</surname><given-names>LM</given-names></name><name><surname>Rizzi</surname><given-names>CJ</given-names></name><name><surname>Yaeger</surname><given-names>LH</given-names></name><name><surname>Chi</surname><given-names>JJ</given-names></name></person-group><article-title>Comparison of autologous vs homologous costal cartilage grafts in dorsal augmentation rhinoplasty: A systematic review and meta-analysis</article-title><source>JAMA Otolaryngol Head Neck Surg</source><volume>146</volume><fpage>347</fpage><lpage>354</lpage><year>2020</year><pub-id pub-id-type="pmid">32077916</pub-id><pub-id pub-id-type="doi">10.1001/jamaoto.2019.4787</pub-id></element-citation></ref>
<ref id="b12-ETM-28-6-12739"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Resuli</surname><given-names>AS</given-names></name><name><surname>Dilber</surname><given-names>M</given-names></name><name><surname>Bayar Muluk</surname><given-names>N</given-names></name><name><surname>Cingi</surname><given-names>C</given-names></name></person-group><article-title>Septal extension graft use in the treatment of alar collapse</article-title><source>Eur Rev Med Pharmacol Sci</source><volume>27 (2 Suppl)</volume><fpage>S8</fpage><lpage>S13</lpage><year>2023</year><pub-id pub-id-type="pmid">36971215</pub-id><pub-id pub-id-type="doi">10.26355/eurrev_202303_31695</pub-id></element-citation></ref>
<ref id="b13-ETM-28-6-12739"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Calvert</surname><given-names>JW</given-names></name><name><surname>Brenner</surname><given-names>K</given-names></name><name><surname>DaCosta-Iyer</surname><given-names>M</given-names></name><name><surname>Evans</surname><given-names>GRD</given-names></name><name><surname>Daniel</surname><given-names>RK</given-names></name></person-group><article-title>Histological analysis of human diced cartilage grafts</article-title><source>Plast Reconstr Surg</source><volume>118</volume><fpage>230</fpage><lpage>236</lpage><year>2006</year><pub-id pub-id-type="pmid">16816701</pub-id><pub-id pub-id-type="doi">10.1097/01.prs.0000220463.73865.78</pub-id></element-citation></ref>
<ref id="b14-ETM-28-6-12739"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manafi</surname><given-names>A</given-names></name><name><surname>Kaviani</surname><given-names>A</given-names></name><name><surname>Hamedi</surname><given-names>ZS</given-names></name><name><surname>Rajabiani</surname><given-names>A</given-names></name><name><surname>Manafi</surname><given-names>N</given-names></name></person-group><article-title>Evidence-based efficacy of autologous grated cartilage in primary and secondary rhinoplasty</article-title><source>World J Plast Surg</source><volume>6</volume><fpage>137</fpage><lpage>143</lpage><year>2017</year><pub-id pub-id-type="pmid">28713702</pub-id></element-citation></ref>
<ref id="b15-ETM-28-6-12739"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>SI</given-names></name><name><surname>Hsiao</surname><given-names>YC</given-names></name><name><surname>Chang</surname><given-names>CS</given-names></name><name><surname>Chen</surname><given-names>PKT</given-names></name><name><surname>Chen</surname><given-names>JP</given-names></name><name><surname>Ueng</surname><given-names>SH</given-names></name></person-group><article-title>Histology and long-term stability of diced cartilage graft for revision rhinoplasty in a cleft patient</article-title><source>Plast Reconstr Surg Glob Open</source><volume>4</volume><issue>e763</issue><year>2016</year><pub-id pub-id-type="pmid">27482502</pub-id><pub-id pub-id-type="doi">10.1097/GOX.0000000000000733</pub-id></element-citation></ref>
<ref id="b16-ETM-28-6-12739"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bender-Heine</surname><given-names>AN</given-names></name><name><surname>Zdilla</surname><given-names>MJ</given-names></name><name><surname>Russell</surname><given-names>ML</given-names></name><name><surname>Rickards</surname><given-names>AA</given-names></name><name><surname>Holmes</surname><given-names>JS</given-names></name><name><surname>Armeni</surname><given-names>MA</given-names></name><name><surname>Lambert</surname><given-names>HW</given-names></name></person-group><article-title>Optimal costal cartilage graft selection according to cartilage shape: anatomical considerations for rhinoplasty</article-title><source>Facial Plast Surg</source><volume>33</volume><fpage>670</fpage><lpage>674</lpage><year>2017</year><pub-id pub-id-type="pmid">29195250</pub-id><pub-id pub-id-type="doi">10.1055/s-0037-1607972</pub-id></element-citation></ref>
<ref id="b17-ETM-28-6-12739"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brenner</surname><given-names>KA</given-names></name><name><surname>McConnell</surname><given-names>MP</given-names></name><name><surname>Evans</surname><given-names>GR</given-names></name><name><surname>Calvert</surname><given-names>JW</given-names></name></person-group><article-title>Survival of diced cartilage grafts: An experimental study</article-title><source>Plast Reconstr Surg</source><volume>117</volume><fpage>105</fpage><lpage>115</lpage><year>2006</year><pub-id pub-id-type="pmid">16404256</pub-id><pub-id pub-id-type="doi">10.1097/01.prs.0000195082.38311.f4</pub-id></element-citation></ref>
<ref id="b18-ETM-28-6-12739"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jurk</surname><given-names>V</given-names></name><name><surname>Kampmann</surname><given-names>H</given-names></name><name><surname>Iblher</surname><given-names>N</given-names></name><name><surname>Bannasch</surname><given-names>H</given-names></name><name><surname>Gubisch</surname><given-names>W</given-names></name></person-group><article-title>Long-term comparison of rib and ear cartilage grafts in autologous and allogenic fascia lata: An experimental study in a white rabbit model</article-title><source>Plast Reconstr Surg</source><volume>137</volume><fpage>1465</fpage><lpage>1474</lpage><year>2016</year><pub-id pub-id-type="pmid">26796374</pub-id><pub-id pub-id-type="doi">10.1097/PRS.0000000000002133</pub-id></element-citation></ref>
<ref id="b19-ETM-28-6-12739"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>SH</given-names></name><name><surname>Suh</surname><given-names>JH</given-names></name><name><surname>Jang</surname><given-names>YJ</given-names></name></person-group><article-title>Histomorphological findings of cartilage and surrounding tissues according to thickness and manipulations in rabbits</article-title><source>Aesthet Surg J</source><volume>42</volume><fpage>NP489</fpage><lpage>NP500</lpage><year>2022</year><pub-id pub-id-type="pmid">35148368</pub-id><pub-id pub-id-type="doi">10.1093/asj/sjac028</pub-id></element-citation></ref>
<ref id="b20-ETM-28-6-12739"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heatley</surname><given-names>DG</given-names></name><name><surname>Clary</surname><given-names>RA</given-names></name><name><surname>Garner</surname><given-names>FT</given-names></name><name><surname>Lusk</surname><given-names>RP</given-names></name></person-group><article-title>Auricular cartilage versus costal cartilage as a grafting material in experimental laryngotracheal reconstruction</article-title><source>Laryngoscope</source><volume>105 (9 Pt 1)</volume><fpage>983</fpage><lpage>987</lpage><year>1995</year><pub-id pub-id-type="pmid">7666735</pub-id><pub-id pub-id-type="doi">10.1288/00005537-199509000-00019</pub-id></element-citation></ref>
<ref id="b21-ETM-28-6-12739"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Milgram</surname><given-names>JW (ed)</given-names></name></person-group><comment>Radiologic and histologic pathology of nontumorous diseases of bones and joints. Northbrook Publishing Co Inc, Northbrook IL, pp21-32, 57-89, 95-112, 1990.</comment></element-citation></ref>
<ref id="b22-ETM-28-6-12739"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ishida</surname><given-names>T</given-names></name><name><surname>Imamura</surname><given-names>T (eds)</given-names></name></person-group><comment>Surgical pathology of non-neoplastic bone and joint diseases. Bunkoudo, Tokyo, pp48-61, pp226-236, 2003 (in Japanese).</comment></element-citation></ref>
<ref id="b23-ETM-28-6-12739"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klein</surname><given-names>MJ</given-names></name><name><surname>Bonar</surname><given-names>SF</given-names></name><name><surname>Freemont</surname><given-names>T</given-names></name><name><surname>Vinh</surname><given-names>TN</given-names></name><name><surname>Lopez-Ben</surname><given-names>R</given-names></name><name><surname>Siegel</surname><given-names>HJ</given-names></name><name><surname>Siegel</surname><given-names>GP</given-names></name></person-group><comment>Non-neoplastic diseases of bones and joints. In: King DW, Gardner WA, Sobin LH, Stocker JT, Wagner B (eds) Atlas of nontumor pathology. first series, fascicle 9. American Registry of Pathology, Washington DC, pp1-53, 85-298, 577-767, 2011.</comment></element-citation></ref>
<ref id="b24-ETM-28-6-12739"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakajima</surname><given-names>H</given-names></name></person-group><article-title>A histological study of the nasal cartilages in man (Japanese adults)</article-title><source>Oto-Rhino-Laryngology Tokyo</source><volume>17</volume><fpage>171</fpage><lpage>202</lpage><year>1974</year><comment>(in Japanese)</comment></element-citation></ref>
<ref id="b25-ETM-28-6-12739"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pawlina</surname><given-names>W</given-names></name></person-group><comment>Histology: a text and atlas: with correlated cell and molecular biology. 9th edition. Wolters Kluwer Business, Philadelphia PA, pp228-237, 2024.</comment></element-citation></ref>
<ref id="b26-ETM-28-6-12739"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maclean</surname><given-names>F</given-names></name></person-group><comment>Joints. In: Mills SE (ed) Histology for Pathologists. 5th edition. Wolters Kluwer, Philadelphia PA: pp113-132, 2020.</comment></element-citation></ref>
<ref id="b27-ETM-28-6-12739"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Machinami</surname><given-names>R</given-names></name></person-group><article-title>Membranous lipodystrophy-like changes in ischemic necrosis of the legs</article-title><source>Virchows Arch A Pathol Anat Histopathol</source><volume>399</volume><fpage>191</fpage><lpage>205</lpage><year>1983</year><pub-id pub-id-type="pmid">6404049</pub-id><pub-id pub-id-type="doi">10.1007/BF00619579</pub-id></element-citation></ref>
<ref id="b28-ETM-28-6-12739"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matsukuma</surname><given-names>S</given-names></name><name><surname>Matsunaga</surname><given-names>A</given-names></name><name><surname>Takahashi</surname><given-names>O</given-names></name><name><surname>Ogata</surname><given-names>S</given-names></name></person-group><article-title>Lipomembranous fat necrosis: A distinctive and unique morphology (Review)</article-title><source>Exp Ther Med</source><volume>24</volume><issue>759</issue><year>2022</year><pub-id pub-id-type="pmid">36561978</pub-id><pub-id pub-id-type="doi">10.3892/etm.2022.11695</pub-id></element-citation></ref>
<ref id="b29-ETM-28-6-12739"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bos</surname><given-names>EJ</given-names></name><name><surname>Pluemeekers</surname><given-names>M</given-names></name><name><surname>Helder</surname><given-names>M</given-names></name><name><surname>Kuzmin</surname><given-names>N</given-names></name><name><surname>van der Laan</surname><given-names>K</given-names></name><name><surname>Groot</surname><given-names>ML</given-names></name><name><surname>van Osch</surname><given-names>G</given-names></name><name><surname>van Zuijlen</surname><given-names>P</given-names></name></person-group><article-title>Structural and mechanical comparison of human ear, alar, and septal cartilage</article-title><source>Plast Reconstr Surg Blob Open</source><volume>6</volume><issue>e1610</issue><year>2018</year><pub-id pub-id-type="pmid">29464156</pub-id><pub-id pub-id-type="doi">10.1097/GOX.0000000000001610</pub-id></element-citation></ref>
<ref id="b30-ETM-28-6-12739"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sinclair</surname><given-names>S</given-names></name><name><surname>Walsh</surname><given-names>WR</given-names></name></person-group><article-title>Characterization of costal cartilage allografts</article-title><source>ANZ J Surg</source><volume>92</volume><fpage>2274</fpage><lpage>2279</lpage><year>2022</year><pub-id pub-id-type="pmid">36097422</pub-id><pub-id pub-id-type="doi">10.1111/ans.17967</pub-id></element-citation></ref>
<ref id="b31-ETM-28-6-12739"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Wei</surname><given-names>L</given-names></name><name><surname>Zeng</surname><given-names>L</given-names></name><name><surname>He</surname><given-names>D</given-names></name><name><surname>Wei</surname><given-names>X</given-names></name></person-group><article-title>Nutrition and degeneration of articular cartilage</article-title><source>Knee Surg Sports Traumatol Arthrosc</source><volume>21</volume><fpage>1751</fpage><lpage>1762</lpage><year>2013</year><pub-id pub-id-type="pmid">22476522</pub-id><pub-id pub-id-type="doi">10.1007/s00167-012-1977-7</pub-id></element-citation></ref>
<ref id="b32-ETM-28-6-12739"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheng</surname><given-names>T</given-names></name><name><surname>Maddox</surname><given-names>NC</given-names></name><name><surname>Wong</surname><given-names>AW</given-names></name><name><surname>Rahnama</surname><given-names>R</given-names></name><name><surname>Kuo</surname><given-names>AC</given-names></name></person-group><article-title>Comparison of gene expression patterns in articular cartilage and dedifferentiated articular chondrocytes</article-title><source>J Orthop Res</source><volume>30</volume><fpage>234</fpage><lpage>245</lpage><year>2012</year><pub-id pub-id-type="pmid">21809379</pub-id><pub-id pub-id-type="doi">10.1002/jor.21503</pub-id></element-citation></ref>
<ref id="b33-ETM-28-6-12739"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hall</surname><given-names>AC</given-names></name></person-group><article-title>The role of chondrocyte morphology and volume in controlling phenotype-Implications for osteoarthritis, cartilage repair, and cartilage engineering</article-title><source>Curr Rheumatol Rep</source><volume>21</volume><issue>38</issue><year>2019</year><pub-id pub-id-type="pmid">31203465</pub-id><pub-id pub-id-type="doi">10.1007/s11926-019-0837-6</pub-id></element-citation></ref>
<ref id="b34-ETM-28-6-12739"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sato</surname><given-names>K</given-names></name><name><surname>Moy</surname><given-names>OJ</given-names></name><name><surname>Peimer</surname><given-names>CA</given-names></name><name><surname>Nakamura</surname><given-names>T</given-names></name><name><surname>Howard</surname><given-names>C</given-names></name><name><surname>Ko</surname><given-names>SH</given-names></name><name><surname>Lee</surname><given-names>TC</given-names></name><name><surname>Nishiwaki</surname><given-names>Y</given-names></name></person-group><article-title>An experimental study on costal osteochondral graft</article-title><source>Osteoarthritis Cartilage</source><volume>20</volume><fpage>172</fpage><lpage>183</lpage><year>2012</year><pub-id pub-id-type="pmid">22179032</pub-id><pub-id pub-id-type="doi">10.1016/j.joca.2011.12.001</pub-id></element-citation></ref>
</ref-list>
</back>
<floats-group>
<fig id="f1-ETM-28-6-12739" position="float">
<label>Figure 1</label>
<caption><p>Typical examples of removed CC (A-E), NC (F-J) and EC (K-O). (A) CC was triangular, and NC (F) and EC (K) exhibited relatively slender and slightly curved features. (A, F and K) Scale bar, 1 mm; H&#x0026;E staining. CC (B) contained evenly distributed chondrocytes, and NC (G) and EC (L) exhibited centrally scarce and peripherally dense chondrocytes. (B, G and L) Scale bar, 200 &#x00B5;m; H&#x0026;E staining. The chondroid matrix in (C) CC and (H) NC was slightly eosinophilic and homogenous, whereas that in EC (M) was brightly reddish. (C, H and M) Scale bar, 50 &#x00B5;m; H&#x0026;E staining. Masson trichrome staining highlighted unstained chondrocytic lacunae, which were somewhat larger in NC (I) than CC (D) and EC (N). (D, I and N) Scale bar, 50 &#x00B5;m; Masson trichrome staining. EVG staining revealed a dense elastic meshwork around lacunae in EC (O), which was different from the occasional, EVG-positive fine deposits in CC (E) and NC (J). (E, J and O) Scale bar, 50 &#x00B5;m; EVG staining. CC, costal cartilage; EC, ear cartilage; EVG, Elastica van Gieson; NC, nasal cartilage.</p></caption>
<graphic xlink:href="etm-28-06-12739-g00.tif" />
</fig>
<fig id="f2-ETM-28-6-12739" position="float">
<label>Figure 2</label>
<caption><p>Histopathology of removed CC. (A) Partially organized ACC (scale bar, 200 &#x00B5;m; H&#x0026;E staining). (B) Patchy organized areas (&#x002A;) containing fibroblasts within massively necrotic IHCC (scale bar, 100 &#x00B5;m; H&#x0026;E staining). (C and D) H&#x0026;E-stained ACC showing (C) fibroblasts in scattered organized areas (white arrowheads). (D) These fibroblasts were negative for PAS staining (white arrowheads) and were intermingled with PAS-positive spindle chondrocytes (arrows), near PAS-positive rounded chondrocytes (black arrowheads). The inset in (D) shows high-power views of PAS-positive spindled chondrocytes. These features implied a possible transition of chondrocytes into fibroblasts. (C) Scale bar, 100 &#x00B5;m; H&#x0026;E staining. (D) Scale bar, 100 &#x00B5;m; PAS staining. (D) Inset scale bar, 10 &#x00B5;m; PAS staining. (E) EVG-positive minimal elastic fibers (arrows) surrounding chondrocyte lacunae in IHCC (scale bar, 50 &#x00B5;m; EVG staining. (F) H&#x0026;E-stained IHCC exhibiting eosinophilic membranous bodies (arrows). The inset shows a high-power view of PAS-positive crenulated, serpiginous membranous changes, mimicking LFN (scale bar, 50 &#x00B5;m; H&#x0026;E staining; inset scale bar, 10 &#x00B5;m, PAS staining). (G) Chondrocytic vacuolar changes (scale bar, 50 &#x00B5;m; H&#x0026;E staining). (H) Intermingled LFN-like body (arrowhead) and vacuolar chondrocyte (arrow). The vacuolar chondrocyte was stained red with Masson trichrome (inset), closely resembling an LFN-like body. These findings suggested a transition between chondrocytic vacuoles and LFN-like bodies (scale bar, 10 &#x00B5;m; H&#x0026;E staining; inset scale bar, 10 &#x00B5;m; Masson trichrome staining). ACC, autologous CC; CC, costal cartilage; EVG, Elastica van Gieson; IHCC, irradiated homologous CC; LFN, lipomembranous fat necrosis; PAS, periodic acid-Schiff.</p></caption>
<graphic xlink:href="etm-28-06-12739-g01.tif" />
</fig>
<fig id="f3-ETM-28-6-12739" position="float">
<label>Figure 3</label>
<caption><p>Histopathology of removed ANC. (A) Organizing fibroblasts invading the chondroid matrix in a striated fashion (arrows; scale bar, 200 &#x00B5;m; H&#x0026;E staining). (B) Large organized chondroid matrix (&#x002A;) and small organized areas containing nested fibroblasts (arrows) (scale bar, 50 &#x00B5;m; H&#x0026;E staining). (C) Granulation-fibrosis (&#x002A;) attached to organizing ANC (scale bar, 200 &#x00B5;m; H&#x0026;E staining). (D) High-power view of transition zones between granulation-fibrosis and ANC &#x005B;square area in (C)&#x005D; revealing PAS-positive spindled chondrocytes (arrows) (scale bar, 50 &#x00B5;m; PAS staining). (E) Fibrocartilaginous nodule (arrows) close to ANC (&#x002A;), and high-power views (inset) of fibrocartilaginous nodule showing numerous PAS-positive spindled chondrocytes (scale bar, 200 &#x00B5;m; inset scale bar, 30 &#x00B5;m; PAS staining). (F) Binucleated and trinucleated chondrocytes (arrow) in enlarged lacunae (scale bar, 10 &#x00B5;m; H&#x0026;E staining). (G) Intermingled eosinophilic membranous bodies (arrow) and vacuolar chondrocyte (arrowhead) (scale bar, 10 &#x00B5;m; H&#x0026;E staining). ANC, autologous nasal cartilage; PAS, periodic acid-Schiff.</p></caption>
<graphic xlink:href="etm-28-06-12739-g02.tif" />
</fig>
<fig id="f4-ETM-28-6-12739" position="float">
<label>Figure 4</label>
<caption><p>Histopathology of removed ear cartilage. (A) Organized areas (arrows) lacking an (B) EVG-positive meshwork (arrows), but preserving (C) Masson trichrome-blue-stained collagens (arrows). (C) Patchy areas exhibiting depletion of collagen blue-stained with Masson trichrome (&#x002A;) but preserving the (B) EVG-positive meshwork (&#x002A;) showing no remarkable changes on (A) H&#x0026;E-stained section (asterisks) close to striated organized areas (arrowheads). (A-C) Scale bar, 100 &#x00B5;m. (A) H&#x0026;E staining. (B) EVG staining. (C) Masson trichrome staining. (D) Organized areas containing spindle cells. (E) On a PAS-stained section, these spindle cells were composed of PAS-positive spindled chondrocytes and PAS-negative fibroblasts. (D and E) Scale bar, 50 &#x00B5;m. (D) H&#x0026;E staining. (E) PAS staining. (F) Scattered eosinophilic membranous bodies (arrows), stained red with (G) Masson trichrome and (H) PAS staining. (F-H) Scale bar, 10 &#x00B5;m. (F) H&#x0026;E staining. (G) Masson trichrome staining. (H) PAS staining. (I) Chondrocyte cloning (scale bar, 10 &#x00B5;m; H&#x0026;E staining). (J) Vacuolar chondrocyte (arrow) and binucleated chondrocyte (scale bar, 10 &#x00B5;m; H&#x0026;E staining). (K) Trinucleated chondrocyte (scale bar, 10 &#x00B5;m; H&#x0026;E staining). EVG, Elastica van Gieson; PAS, periodic acid-Schiff.</p></caption>
<graphic xlink:href="etm-28-06-12739-g03.tif" />
</fig>
<fig id="f5-ETM-28-6-12739" position="float">
<label>Figure 5</label>
<caption><p>Comparison of clinicopathological findings among cartilaginous types. (A) There was no significant difference in the ITI among ACC, IHCC, ANC and EC (P=0.554)<sup>a</sup>. (B) Chondrocytic viability in IHCC was significantly lower than that in ACC, ANC and EC, whereas that in EC was significantly lower than that in ACC and ANC<sup>a,b</sup>. (C) There was no significant difference in the organized rate of chondroid matrix among ACC, IHCC, ANC and EC (P=0.909)<sup>a</sup>. (D) The grading score of enlarged chondrocyte lacunae in EC was significantly lower than that in ACC, IHCC and ANC<sup>a,b</sup>. (E) The grading score of LFN-like bodies in ACC was significantly higher than that in ANC and EC, and that in IHCC was higher than that in ANC<sup>a,b</sup>. (F) The grading score of chondrocyte cloning in EC was significantly lower than that in ACC and ANC<sup>a,b</sup>. (G) There was no significant difference in the grading score of binucleated chondrocytes among ACC, ANC and EC (P=0.098)<sup>a</sup>. (H) The grading score of chondrocytic vacuolar changes in ACC was significantly higher than that in ANC and EC<sup>a,b</sup>. <sup>&#x002A;</sup>P&#x003C;0.05. <sup>a</sup>Kruskal-Wallis H-test; <sup>b</sup>Mann-Whitney U-test with Bonferroni correction. ACC, autologous costal cartilage; ANC, autologous nasal cartilage; EC, ear cartilage; IHCC, irradiated homologous costal cartilage; ITI, implantation time interval; LFN, lipomembranous fat necrosis.</p></caption>
<graphic xlink:href="etm-28-06-12739-g04.tif" />
</fig>
<table-wrap id="tI-ETM-28-6-12739" position="float">
<label>Table I</label>
<caption><p>Clinical findings in 42 patients who underwent removal of cartilaginous grafts.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="middle">Variable</th>
<th align="center" valign="middle">Value</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="middle">Age range, years (median)</td>
<td align="center" valign="middle">21-47 (28.0)</td>
</tr>
<tr>
<td align="left" valign="middle">Sex, n (male/female)</td>
<td align="center" valign="middle">2/40</td>
</tr>
<tr>
<td align="left" valign="middle">Range of time interval between implantation and the removal of grafts, months (median)</td>
<td align="center" valign="middle">0.3-132.0 (18.0)</td>
</tr>
<tr>
<td align="left" valign="middle">Complaints/reasons for correction/revision rhinoplasty, n (&#x0025;)<sup><xref rid="tfna-ETM-28-6-12739" ref-type="table-fn">a</xref></sup></td>
<td align="center" valign="middle">&#x00A0;</td>
</tr>
<tr>
<td align="left" valign="middle">&#x00A0;&#x00A0;&#x00A0;&#x00A0;&#x00A0;Nasal deformity</td>
<td align="center" valign="middle">24 (57.1)</td>
</tr>
<tr>
<td align="left" valign="middle">&#x00A0;&#x00A0;&#x00A0;&#x00A0;&#x00A0;Nasal discomfort</td>
<td align="center" valign="middle">15 (35.7)</td>
</tr>
<tr>
<td align="left" valign="middle">&#x00A0;&#x00A0;&#x00A0;&#x00A0;&#x00A0;Skin thinning at implantation site</td>
<td align="center" valign="middle">10 (23.8)</td>
</tr>
<tr>
<td align="left" valign="middle">&#x00A0;&#x00A0;&#x00A0;&#x00A0;&#x00A0;Restriction on laughing movement</td>
<td align="center" valign="middle">3 (7.1)</td>
</tr>
<tr>
<td align="left" valign="middle">&#x00A0;&#x00A0;&#x00A0;&#x00A0;&#x00A0;Suspicious infection at implantation site</td>
<td align="center" valign="middle">2 (4.8)</td>
</tr>
<tr>
<td align="left" valign="middle">&#x00A0;&#x00A0;&#x00A0;&#x00A0;&#x00A0;Nasal cavity hematoma</td>
<td align="center" valign="middle">1 (2.4)</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="tfna-ETM-28-6-12739"><p><sup>a</sup>A total of 9 patients had complicated complaints/reasons for correction/revision rhinoplasty.</p></fn>
</table-wrap-foot>
</table-wrap>
<table-wrap id="tII-ETM-28-6-12739" position="float">
<label>Table II</label>
<caption><p>Histological type of 83 cartilaginous graft specimens removed from 42 patients.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="middle">Cartilaginous graft type</th>
<th align="center" valign="middle">Number</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="middle">Costal hyaline cartilage only</td>
<td align="center" valign="middle">30</td>
</tr>
<tr>
<td align="left" valign="middle">&#x00A0;&#x00A0;&#x00A0;&#x00A0;&#x00A0;ACC only</td>
<td align="center" valign="middle">14</td>
</tr>
<tr>
<td align="left" valign="middle">&#x00A0;&#x00A0;&#x00A0;&#x00A0;&#x00A0;IHCC only</td>
<td align="center" valign="middle">16</td>
</tr>
<tr>
<td align="left" valign="middle">Nasal hyaline cartilage only</td>
<td align="center" valign="middle">26</td>
</tr>
<tr>
<td align="left" valign="middle">&#x00A0;&#x00A0;&#x00A0;&#x00A0;&#x00A0;ANC only</td>
<td align="center" valign="middle">24</td>
</tr>
<tr>
<td align="left" valign="middle">&#x00A0;&#x00A0;&#x00A0;&#x00A0;&#x00A0;IHNC only</td>
<td align="center" valign="middle">2</td>
</tr>
<tr>
<td align="left" valign="middle">Autologous ear elastic cartilage only</td>
<td align="center" valign="middle">14</td>
</tr>
<tr>
<td align="left" valign="middle">Combined graft</td>
<td align="center" valign="middle">13</td>
</tr>
<tr>
<td align="left" valign="middle">&#x00A0;&#x00A0;&#x00A0;&#x00A0;&#x00A0;ANC + EC</td>
<td align="center" valign="middle">3</td>
</tr>
<tr>
<td align="left" valign="middle">&#x00A0;&#x00A0;&#x00A0;&#x00A0;&#x00A0;ANC + artificial graft</td>
<td align="center" valign="middle">3</td>
</tr>
<tr>
<td align="left" valign="middle">&#x00A0;&#x00A0;&#x00A0;&#x00A0;&#x00A0;EC + artificial graft</td>
<td align="center" valign="middle">3</td>
</tr>
<tr>
<td align="left" valign="middle">&#x00A0;&#x00A0;&#x00A0;&#x00A0;&#x00A0;IHCC + ANC + EC</td>
<td align="center" valign="middle">2</td>
</tr>
<tr>
<td align="left" valign="middle">&#x00A0;&#x00A0;&#x00A0;&#x00A0;&#x00A0;ACC + ANC</td>
<td align="center" valign="middle">1</td>
</tr>
<tr>
<td align="left" valign="middle">&#x00A0;&#x00A0;&#x00A0;&#x00A0;&#x00A0;ACC + EC</td>
<td align="center" valign="middle">1</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn><p>ACC, autologous costal cartilage; ANC, autologous nasal cartilage; EC, elastic cartilage; IHCC, irradiated homologous costal cartilage; IHNC, irradiated homologous nasal cartilage.</p></fn>
</table-wrap-foot>
</table-wrap>
<table-wrap id="tIII-ETM-28-6-12739" position="float">
<label>Table III</label>
<caption><p>Clinicopathological findings of 83 cartilaginous grafts<sup><xref rid="tfn1-a-ETM-28-6-12739" ref-type="table-fn">a</xref></sup> surgically removed from 42 patients.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="middle">&#x00A0;</th>
<th align="center" valign="middle" colspan="2">Costal cartilage (n=34<sup><xref rid="tfn1-a-ETM-28-6-12739" ref-type="table-fn">a</xref></sup>)</th>
<th align="center" valign="middle" colspan="2">Nasal cartilage (n=35<sup><xref rid="tfn1-a-ETM-28-6-12739" ref-type="table-fn">a</xref></sup>)</th>
<th align="center" valign="middle">&#x00A0;</th>
</tr>
<tr>
<th align="left" valign="middle">Variable</th>
<th align="center" valign="middle">ACC (n=16)</th>
<th align="center" valign="middle">IHCC (n=18)</th>
<th align="center" valign="middle">ANC (n=33)</th>
<th align="center" valign="middle">IHNC (n=2)</th>
<th align="center" valign="middle">Ear cartilage (n=23<sup><xref rid="tfn1-a-ETM-28-6-12739" ref-type="table-fn">a</xref></sup>)</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="middle">Patients, n</td>
<td align="center" valign="middle">11</td>
<td align="center" valign="middle">15</td>
<td align="center" valign="middle">18</td>
<td align="center" valign="middle">1</td>
<td align="center" valign="middle">18</td>
</tr>
<tr>
<td align="left" valign="middle">Age range, years (median)</td>
<td align="center" valign="middle">22-47 (25.0)</td>
<td align="center" valign="middle">21-45 (29.0)</td>
<td align="center" valign="middle">21-47 (28.5)</td>
<td align="center" valign="middle">35</td>
<td align="center" valign="middle">21-47 (30.5)</td>
</tr>
<tr>
<td align="left" valign="middle">Sex, n (male/female)</td>
<td align="center" valign="middle">1/10</td>
<td align="center" valign="middle">0/15</td>
<td align="center" valign="middle">1/17</td>
<td align="center" valign="middle">0/1</td>
<td align="center" valign="middle">0/18</td>
</tr>
<tr>
<td align="left" valign="middle">ITI<sup><xref rid="tfn1-b-ETM-28-6-12739" ref-type="table-fn">b</xref></sup> range, months (median)</td>
<td align="center" valign="middle">1.0-35.0 (12.0)</td>
<td align="center" valign="middle">0.8-119.0 (9.0)</td>
<td align="center" valign="middle">0.3-72.0 (13.0)</td>
<td align="center" valign="middle">12.0</td>
<td align="center" valign="middle">1.0-132.0 (11.5)</td>
</tr>
<tr>
<td align="left" valign="middle">Histopathological findings</td>
<td align="center" valign="middle">&#x00A0;</td>
<td align="center" valign="middle">&#x00A0;</td>
<td align="center" valign="middle">&#x00A0;</td>
<td align="center" valign="middle">&#x00A0;</td>
<td align="center" valign="middle">&#x00A0;</td>
</tr>
<tr>
<td align="left" valign="middle">&#x00A0;&#x00A0;&#x00A0;&#x00A0;&#x00A0;Presence of viable chondrocytes, n (&#x0025;)</td>
<td align="center" valign="middle">16 (100.0)</td>
<td align="center" valign="middle">3 (16.7)</td>
<td align="center" valign="middle">33 (100.0)</td>
<td align="center" valign="middle">2 (100.0)</td>
<td align="center" valign="middle">20 (87.0)</td>
</tr>
<tr>
<td align="left" valign="middle">&#x00A0;&#x00A0;&#x00A0;&#x00A0;&#x00A0;Range of chondrocytic viability, &#x0025; (median)</td>
<td align="center" valign="middle">21.5-60.0 (35.9)</td>
<td align="center" valign="middle">0-10.1 (0.0)</td>
<td align="center" valign="middle">9.0-63.5 (41.3)</td>
<td align="center" valign="middle">24.8-26.6 (25.8)</td>
<td align="center" valign="middle">0-50.0 (21.4)</td>
</tr>
<tr>
<td align="left" valign="middle">&#x00A0;&#x00A0;&#x00A0;&#x00A0;&#x00A0;Organization (replacement fibrosis) of chondroid matrix, n (&#x0025;)</td>
<td align="center" valign="middle">16 (100.0)</td>
<td align="center" valign="middle">16 (88.9)</td>
<td align="center" valign="middle">22 (62.9)</td>
<td align="center" valign="middle">2 (100.0)</td>
<td align="center" valign="middle">20 (87.0)</td>
</tr>
<tr>
<td align="left" valign="middle">&#x00A0;&#x00A0;&#x00A0;&#x00A0;&#x00A0;Range of organized rate of cartilaginous matrix, &#x0025; (median)</td>
<td align="center" valign="middle">0.1-11.0 (2.5)</td>
<td align="center" valign="middle">0-24.0 (1.4)</td>
<td align="center" valign="middle">0-22.0 (0.9)</td>
<td align="center" valign="middle">0.1 (0.1)</td>
<td align="center" valign="middle">0-50.0 (2.0)</td>
</tr>
<tr>
<td align="left" valign="middle">&#x00A0;&#x00A0;&#x00A0;&#x00A0;&#x00A0;Granulation-fibrosis surrounding cartilaginous grafts, n (&#x0025;)</td>
<td align="center" valign="middle">11 (68.8)</td>
<td align="center" valign="middle">9 (50.0)</td>
<td align="center" valign="middle">24 (72.7)</td>
<td align="center" valign="middle">1 (50.0)</td>
<td align="center" valign="middle">22 (95.7)</td>
</tr>
<tr>
<td align="left" valign="middle">&#x00A0;&#x00A0;&#x00A0;&#x00A0;&#x00A0;Possible transition between chondrocytes and fibroblasts, n (&#x0025;)</td>
<td align="center" valign="middle">6 (37.5)</td>
<td align="center" valign="middle">0 (0.0)</td>
<td align="center" valign="middle">3 (9.1)</td>
<td align="center" valign="middle">0 (0.0)</td>
<td align="center" valign="middle">1 (4.3)</td>
</tr>
<tr>
<td align="left" valign="middle">&#x00A0;&#x00A0;&#x00A0;&#x00A0;&#x00A0;Grading score of enlarged chondrocytic lacunae, n (0/1/2/3/4/5) (median)</td>
<td align="center" valign="middle">2/2/2/4/5/1 (3.0)</td>
<td align="center" valign="middle">0/3/1/8/4/2 (3.0)</td>
<td align="center" valign="middle">2/13/9/6/2/1 (2.0)</td>
<td align="center" valign="middle">0/0/0/0/2/0 (4.0)</td>
<td align="center" valign="middle">7/13/2/1/0/0 (1.0)</td>
</tr>
<tr>
<td align="left" valign="middle">&#x00A0;&#x00A0;&#x00A0;&#x00A0;&#x00A0;Ossification, n (&#x0025;)</td>
<td align="center" valign="middle">2 (12.5)</td>
<td align="center" valign="middle">2 (11.1)</td>
<td align="center" valign="middle">5 (15.1)</td>
<td align="center" valign="middle">0 (0.0)</td>
<td align="center" valign="middle">0 (0.0)</td>
</tr>
<tr>
<td align="left" valign="middle">&#x00A0;&#x00A0;&#x00A0;&#x00A0;&#x00A0;Lymphoid infiltration, n (&#x0025;)</td>
<td align="center" valign="middle">5 (31.3)</td>
<td align="center" valign="middle">6 (33.3)</td>
<td align="center" valign="middle">11 (33.3)</td>
<td align="center" valign="middle">0 (0.0)</td>
<td align="center" valign="middle">7 (30.4)</td>
</tr>
<tr>
<td align="left" valign="middle">&#x00A0;&#x00A0;&#x00A0;&#x00A0;&#x00A0;Focal and minimal EVG-positive elastic fibers<sup><xref rid="tfn1-c-ETM-28-6-12739" ref-type="table-fn">c</xref></sup>, n (&#x0025;)</td>
<td align="center" valign="middle">8 (50.0)</td>
<td align="center" valign="middle">6 (33.3)</td>
<td align="center" valign="middle">0 (0.0)</td>
<td align="center" valign="middle">0 (0.0)</td>
<td align="center" valign="middle">NA</td>
</tr>
<tr>
<td align="left" valign="middle">&#x00A0;&#x00A0;&#x00A0;&#x00A0;&#x00A0;LFN-like bodies<sup><xref rid="tfn1-d-ETM-28-6-12739" ref-type="table-fn">d</xref></sup>, n (&#x0025;)</td>
<td align="center" valign="middle">15 (93.8)</td>
<td align="center" valign="middle">14 (77.8)</td>
<td align="center" valign="middle">3 (9.1)</td>
<td align="center" valign="middle">0 (0.0)</td>
<td align="center" valign="middle">5 (21.8)</td>
</tr>
<tr>
<td align="left" valign="middle">&#x00A0;&#x00A0;&#x00A0;&#x00A0;&#x00A0;Grading score of LFN-like bodies<sup><xref rid="tfn1-d-ETM-28-6-12739" ref-type="table-fn">d</xref></sup>, n (0/1/2/3/4/5) (median)</td>
<td align="center" valign="middle">1/7/3/3/2/0 (1.5)</td>
<td align="center" valign="middle">4/9/1/1/2/1 (1.0)</td>
<td align="center" valign="middle">30/3/0/0/0/0 (0.0)</td>
<td align="center" valign="middle">2/0/0/0/0/0 (0.0)</td>
<td align="center" valign="middle">18/4/0/1/0/0 (0.0)</td>
</tr>
<tr>
<td align="left" valign="middle">&#x00A0;&#x00A0;&#x00A0;&#x00A0;&#x00A0;Multinucleated histiocytes/foreign body reaction, n (&#x0025;)</td>
<td align="center" valign="middle">1 (6.3)</td>
<td align="center" valign="middle">1 (5.6)</td>
<td align="center" valign="middle">0 (0.0)</td>
<td align="center" valign="middle">0 (0.0)</td>
<td align="center" valign="middle">1 (4.3)</td>
</tr>
<tr>
<td align="left" valign="middle">&#x00A0;&#x00A0;&#x00A0;&#x00A0;&#x00A0;Histopathological features of viable chondrocytes</td>
<td align="center" valign="middle">&#x00A0;</td>
<td align="center" valign="middle">&#x00A0;</td>
<td align="center" valign="middle">&#x00A0;</td>
<td align="center" valign="middle">&#x00A0;</td>
<td align="center" valign="middle">&#x00A0;</td>
</tr>
<tr>
<td align="left" valign="middle">&#x00A0;&#x00A0;&#x00A0;&#x00A0;&#x00A0;&#x00A0;&#x00A0;&#x00A0;&#x00A0;&#x00A0;Grading score of cloning features, n (0/1/2/3/4/5) (median)</td>
<td align="center" valign="middle">2/1/8/2/3/0 (2.0)</td>
<td align="center" valign="middle">18/0/0/0/0/0 (0.0)</td>
<td align="center" valign="middle">0/16/10/5/1/1 (2.0)</td>
<td align="center" valign="middle">0/0/0/2/0/0 (3.0)</td>
<td align="center" valign="middle">10/11/2/0/0/0 (1.0)</td>
</tr>
<tr>
<td align="left" valign="middle">&#x00A0;&#x00A0;&#x00A0;&#x00A0;&#x00A0;&#x00A0;&#x00A0;&#x00A0;&#x00A0;&#x00A0;Grading score of binucleated chondrocytes, n (0/1/2/3/4/5) (median)</td>
<td align="center" valign="middle">1/10/1/0/4/0 (1.0)</td>
<td align="center" valign="middle">18/0/0/0/0/0 (0)</td>
<td align="center" valign="middle">3/19/8/3/0/0 (1.0)</td>
<td align="center" valign="middle">0/0/2/0/0/0 (2.0)</td>
<td align="center" valign="middle">5/5/1/5/7/0 (3.0)</td>
</tr>
<tr>
<td align="left" valign="middle">&#x00A0;&#x00A0;&#x00A0;&#x00A0;&#x00A0;Trinucleated chondrocytes, n (&#x0025;)</td>
<td align="center" valign="middle">0 (0.0)</td>
<td align="center" valign="middle">0 (0.0)</td>
<td align="center" valign="middle">8 (24.2)</td>
<td align="center" valign="middle">2 (100.0)</td>
<td align="center" valign="middle">2 (8.7)</td>
</tr>
<tr>
<td align="left" valign="middle">&#x00A0;&#x00A0;&#x00A0;&#x00A0;&#x00A0;Vacuolar changes, n (&#x0025;)</td>
<td align="center" valign="middle">15 (93.8)</td>
<td align="center" valign="middle">0 (0.0)</td>
<td align="center" valign="middle">22 (66.7)</td>
<td align="center" valign="middle">2 (100.0)</td>
<td align="center" valign="middle">16 (70.0)</td>
</tr>
<tr>
<td align="left" valign="middle">&#x00A0;&#x00A0;&#x00A0;&#x00A0;&#x00A0;&#x00A0;&#x00A0;&#x00A0;&#x00A0;&#x00A0;Grading score of vacuolar changes, n (0/1/2/3/4/5) (median)</td>
<td align="center" valign="middle">1/4/1/3/5/2 (23.0)</td>
<td align="center" valign="middle">18/0/0/0/0/0 (0.0)</td>
<td align="center" valign="middle">11/18/4/0/0/0 (1.0)</td>
<td align="center" valign="middle">0/2/0/0/0/0 (1.0)</td>
<td align="center" valign="middle">7/12/3/1/0/0 (1.0)</td>
</tr>
<tr>
<td align="left" valign="middle">&#x00A0;&#x00A0;&#x00A0;&#x00A0;&#x00A0;Transition between LFN-like bodies<sup><xref rid="tfn1-d-ETM-28-6-12739" ref-type="table-fn">d</xref></sup> and chondrocytic vacuoles, n (&#x0025;)</td>
<td align="center" valign="middle">2 (12.5)</td>
<td align="center" valign="middle">0 (0.0)</td>
<td align="center" valign="middle">1 (3.0)</td>
<td align="center" valign="middle">0 (0.0)</td>
<td align="center" valign="middle">0 (0.0)</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="tfn1-a-ETM-28-6-12739"><p><sup>a</sup>Including 13 combined grafts (3, ANC + ear cartilage; 3, ANC + artificial graft; 3, ear cartilage + artificial graft; 2, IHCC + ANC + ear cartilage; 1, ACC + ANC; and 1, ACC + ear cartilage).</p></fn>
<fn id="tfn1-b-ETM-28-6-12739"><p><sup>b</sup>Defined as time interval between implantation and the removal of grafts.</p></fn>
<fn id="tfn1-c-ETM-28-6-12739"><p><sup>c</sup>Possibly newly developed elastic fibers surrounding chondrocytic lacunae.</p></fn>
<fn id="tfn1-d-ETM-28-6-12739"><p><sup>d</sup>Defined as eosinophilic serpiginous membranous bodies on hematoxylin and eosin-stained sections, which were slightly red with Masson trichrome staining and periodic acid-Schiff staining. ACC, autologous costal cartilage; ANC, autologous nasal cartilage; EVG, elastica van Gieson; IHCC, irradiated homologous costal cartilage; IHNC, irradiated homologous nasal cartilage; ITI, implantation time interval; LFN, lipomembranous fat necrosis; NA, not applicable.</p></fn>
</table-wrap-foot>
</table-wrap>
<table-wrap id="tIV-ETM-28-6-12739" position="float">
<label>Table IV</label>
<caption><p>Relationship between eosinophilic membranous bodies and chondrocytic vacuolar changes in removed cartilaginous grafts.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="middle">&#x00A0;</th>
<th align="center" valign="middle" colspan="2">Grading scores of viable chondrocytic vacuolar changes</th>
<th align="center" valign="middle">&#x00A0;</th>
</tr>
<tr>
<th align="left" valign="middle">Histopathological findings</th>
<th align="center" valign="middle">0-1</th>
<th align="center" valign="middle">2-5</th>
<th align="center" valign="middle">P-value</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="middle">Grading scores of LFN-like bodies in ACC, score 0-1/2-5 (n=16)</td>
<td align="center" valign="middle">5/3</td>
<td align="center" valign="middle">0/8</td>
<td align="center" valign="middle">0.026<sup><xref rid="tfn2-a-ETM-28-6-12739" ref-type="table-fn">a</xref>,<xref rid="tfn2-b-ETM-28-6-12739" ref-type="table-fn">b</xref></sup></td>
</tr>
<tr>
<td align="left" valign="middle">Grading scores of LFN-like bodies in IHCC, score 0-1/2-5 (n=18)</td>
<td align="center" valign="middle">13/5</td>
<td align="center" valign="middle">0/0</td>
<td align="center" valign="middle">NA</td>
</tr>
<tr>
<td align="left" valign="middle">LFN-like bodies in ANC, present/none (n=33)</td>
<td align="center" valign="middle">2/27</td>
<td align="center" valign="middle">1/3</td>
<td align="center" valign="middle">0.330<sup><xref rid="tfn2-a-ETM-28-6-12739" ref-type="table-fn">a</xref></sup></td>
</tr>
<tr>
<td align="left" valign="middle">LFN-like bodies in EC, present/none (n=23)</td>
<td align="center" valign="middle">3/16</td>
<td align="center" valign="middle">1/3</td>
<td align="center" valign="middle">0.194<sup><xref rid="tfn2-a-ETM-28-6-12739" ref-type="table-fn">a</xref></sup></td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="tfn2-a-ETM-28-6-12739"><p><sup>a</sup>Fisher&#x0027;s exact test.</p></fn>
<fn id="tfn2-b-ETM-28-6-12739"><p><sup>b</sup>Statistically significant. ACC, autologous costal cartilage; ANC, autologous nasal cartilage; EC, ear cartilage; IHCC, irradiated homologous costal cartilage; LFN, lipomembranous fat necrosis; NA, not applicable.</p></fn>
</table-wrap-foot>
</table-wrap>
<table-wrap id="tV-ETM-28-6-12739" position="float">
<label>Table V</label>
<caption><p>Relationship between binucleated chondrocytes and trinucleated chondrocytes.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="middle">&#x00A0;</th>
<th align="center" valign="middle" colspan="2">Grading scores of binucleated chondrocytes</th>
<th align="center" valign="middle">&#x00A0;</th>
</tr>
<tr>
<th align="left" valign="middle">Histopathological findings</th>
<th align="center" valign="middle">0-1</th>
<th align="center" valign="middle">2-5</th>
<th align="center" valign="middle">P-value</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="middle">Trinucleated chondrocytes in ANC, present/none (n=33)</td>
<td align="center" valign="middle">1/21</td>
<td align="center" valign="middle">7/4</td>
<td align="center" valign="middle">0.001<sup><xref rid="tfn3-a-ETM-28-6-12739" ref-type="table-fn">a</xref>,<xref rid="tfn3-b-ETM-28-6-12739" ref-type="table-fn">b</xref></sup></td>
</tr>
<tr>
<td align="left" valign="middle">Trinucleated chondrocytes in EC, present/none (n=23)</td>
<td align="center" valign="middle">3/16</td>
<td align="center" valign="middle">1/3</td>
<td align="center" valign="middle">0.486<sup><xref rid="tfn3-a-ETM-28-6-12739" ref-type="table-fn">a</xref></sup></td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="tfn3-a-ETM-28-6-12739"><p><sup>a</sup>Fisher&#x0027;s exact test.</p></fn>
<fn id="tfn3-b-ETM-28-6-12739"><p><sup>b</sup>Statistically significant. ANC, autologous nasal cartilage; EC, ear cartilage.</p></fn>
</table-wrap-foot>
</table-wrap>
</floats-group>
</article>
